What Researchers Did
Researchers retrospectively compared 47 thromboangiitis obliterans patients receiving hyperbaric oxygen treatment plus conventional care with 50 patients receiving only conventional care.
What They Found
The hyperbaric oxygen treatment group showed a significantly lower major amputation rate (2/47 vs. 13/50, p<0.001) and better wound healing (40/47 vs. 18/50, p<0.001). Additionally, rest pain control was significantly improved in the HBOT group compared to the control group (42/47 vs. 20/50, p<0.001).
What This Means for Canadian Patients
For Canadian patients with thromboangiitis obliterans experiencing non-healing ischemic wounds and severe pain, hyperbaric oxygen treatment may offer benefits in wound healing and pain control. This could potentially reduce the risk of major amputations when added to conventional care.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Turkey.
Study Limitations
This was a retrospective, non-randomized study, which limits the reliability and generalizability of its findings.